|
PGM2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.254400E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.423400E-01 |
| Normal-vs-Stage2 |
6.553600E-01 |
| Normal-vs-Stage3 |
5.485700E-02 |
| Normal-vs-Stage4 |
1.283970E-02 |
| Stage1-vs-Stage2 |
3.725800E-01 |
| Stage1-vs-Stage3 |
4.521500E-03 |
| Stage1-vs-Stage4 |
6.560200E-04 |
| Stage2-vs-Stage3 |
2.923800E-01 |
| Stage2-vs-Stage4 |
1.093400E-01 |
| Stage3-vs-Stage4 |
4.368600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.498800E-01 |
| Normal-vs-AfricanAmerican |
3.830800E-01 |
| Normal-vs-Asian |
8.615400E-01 |
| Caucasian-vs-AfricanAmerican |
7.323600E-01 |
| Caucasian-vs-Asian |
9.013600E-01 |
| AfricanAmerican-vs-Asian |
8.126200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.467400E-01 |
| Normal-vs-Female |
2.468000E-01 |
| Male-vs-Female |
5.614400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.430600E-01 |
| Normal-vs-Age(41-60Yrs) |
5.532800E-01 |
| Normal-vs-Age(61-80Yrs) |
2.872800E-01 |
| Normal-vs-Age(81-100Yrs) |
1.461640E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.605000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.421000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.092400E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.734000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.455700E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.564100E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
7.627600E-02 |
| Normal-vs-Grade 2 |
5.143400E-01 |
| Normal-vs-Grade 3 |
5.632100E-02 |
| Normal-vs-Grade 4 |
1.565620E-02 |
| Grade 1-vs-Grade 2 |
2.192800E-01 |
| Grade 1-vs-Grade 3 |
1.023590E-02 |
| Grade 1-vs-Grade 4 |
1.318340E-02 |
| Grade 2-vs-Grade 3 |
1.059250E-03 |
| Grade 2-vs-Grade 4 |
8.951100E-04 |
| Grade 3-vs-Grade 4 |
2.738800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
6.428400E-01 |
| Normal-vs-ccB subtype |
3.704000E-01 |
| ccA subtype-vs-ccB subtype |
1.058000E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.943600E-01 |
| Normal-vs-N1 |
6.388000E-01 |
| N0-vs-N1 |
7.946400E-01 |
|
|
